Taiwan to Decide on Over-the-Counter Emergency Contraceptives by Year-End

Taiwan's Ministry of Health and Welfare (MOHW) is set to make a decision by the end of the year on whether to reclassify emergency contraceptive pills, a move that has sparked public attention and concern. The ministry is currently evaluating two primary proposals regarding the accessibility of these medications.

The first option, termed "direct reclassification," would transition emergency contraceptives from prescription-only status to over-the-counter (OTC) availability, allowing individuals to purchase them directly at pharmacies. The second proposal, a "phased dual-track model," draws inspiration from Japan's system. This approach would maintain prescription access through medical channels while simultaneously permitting access to emergency contraceptives without a prescription at specific pharmacies for urgent use, provided the indications remain the same.

“

The traceability and tracking management measures are still in the pre-announcement stage. They will not be implemented before complementary measures are in place, so the public need not worry. The traceability system absolutely does not mean 'strict control' as the public imagines; it will not increase obstacles for the public to obtain emergency contraceptives.

This discussion gained momentum after the Food and Drug Administration (FDA) announced its intention to include three types of emergency contraceptive pills in a system requiring traceability or tracking. This announcement led to public anxiety that the MOHW might implement stricter controls, potentially making it harder for women to obtain the medication. However, MOHW Minister Shyr Jyh-chyuan has assured the public that the traceability measures are still in the pre-announcement phase and will not be implemented without complementary measures. He emphasized that the system aims to monitor the flow of drugs through medical institutions and pharmacies to ensure legal distribution, not to track individual users.

“

Both suggested options are possible choices. Whether emergency contraceptives are reclassified and how the traceability system is managed will be handled together, implemented together while balancing safety and the public's medication needs.

The debate has also involved political figures. Legislator Chen Chao-chao criticized former legislator Lin Ching-yi for allegedly pressuring the FDA years ago to prevent emergency contraceptives from being reclassified as OTC drugs. Lin Ching-yi, now a deputy minister at MOHW, has been vocal on the issue. Huang Shu-ying, executive director of the Taiwan Women's Link, defended Lin's involvement, stating that it is natural for legislators to be concerned about policy, just as Chen Chao-chao is concerned about the reclassification.

Minister Shyr stated that the MOHW will consider both reclassification and the traceability system in tandem, aiming to balance safety with the public's need for medication. The final decision, expected by year-end, will address how these crucial medications are managed and accessed in Taiwan.

“

It is natural for Lin Ching-yi, as a legislator at the time, to be concerned about policy, just as Chen Chao-chao is concerned about the reclassification of emergency contraceptives. Therefore, do not say Lin intervened or should resign; Chen Chao-chao is doing the same thing.